Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Clinical A/Prof Greg Katsoulotos
COPD Cases
A/Prof Ralph Audehm & Prof Genie Pedagogos
The Role of SGLT2 Inhibitors in Preventing Dialysis
Dr Belinda Welsh
Rosacea – Smarter Diagnosis and State-of-the-Art Care
Prof Jason Ong
Syphilis is on the Rise – What GPs Can do to Turn it Around
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
